Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: A double-blind, placebo-controlled trial

被引:89
作者
Schmitt, WJ [1 ]
Slowey, E
Fravi, N
Weber, S
Burgunder, JM
机构
[1] Inselspital Bern, Dept Psychiat, CH-3010 Bern, Switzerland
[2] Inselspital Bern, Dept Neurol, CH-3010 Bern, Switzerland
来源
HEADACHE | 2001年 / 41卷 / 07期
关键词
chronic tension-type headache; botulinum toxin; placebo-controlled study;
D O I
10.1046/j.1526-4610.2001.041007658.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In addition to vascular and supraspinal influences, contraction of craniofacial muscles or central sensitization processes following continuous nociceptive input of craniofacial muscles may play an important role in the pathogenesis of tension-type headache. Chemodenervation induced by botulinum toxin injection is successfully used to decrease muscle tension. If muscle tension is important in this type of headache, then botulinum toxin could be helpful in its treatment. We conducted a randomized, placebo-controlled study to examine the effect of 20 U botulinum toxin injected into frontal and temporal muscles in patients with chronic tension-type headache. During a baseline of 4 weeks and a posttreatment period of 8 weeks, the effect was evaluated with daily records and the West Haven-Yale Multidimensional Pain Inventory. Some improvement in affective variables were demonstrated in the botulinum group, but important outcome variables, such as pain intensity, the number of pain-free days, and consumption of analgesics, were not statistically different between the groups. Reasons for these moderate effects may include the injection sites, dose of botulinum toxin, and duration of treatment.
引用
收藏
页码:658 / 664
页数:7
相关论文
共 19 条
[1]  
*AD HOC COMM CLASS, 1962, JAMA-J AM MED ASSOC, V12, P378
[2]   MIGRAINE AND MUSCLE-CONTRACTION HEADACHES - A CONTINUUM [J].
FEATHERSTONE, HJ .
HEADACHE, 1985, 25 (04) :194-198
[3]  
Flor H, 1990, Schmerz, V4, P82, DOI 10.1007/BF02527839
[4]   CONTROLLED TRIAL OF BOTULINUM TOXIN INJECTIONS IN THE TREATMENT OF SPASMODIC TORTICOLLIS [J].
GELB, DJ ;
LOWENSTEIN, DH ;
AMINOFF, MJ .
NEUROLOGY, 1989, 39 (01) :80-84
[5]   DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BOTULINUM TOXIN INJECTIONS FOR THE TREATMENT OF SPASMODIC TORTICOLLIS [J].
GREENE, P ;
KANG, U ;
FAHN, S ;
BRIN, M ;
MOSKOWITZ, C ;
FLASTER, E .
NEUROLOGY, 1990, 40 (08) :1213-1218
[6]   THE PSYCHOPHYSIOLOGICAL ETIOLOGY OF MUSCLE-CONTRACTION HEADACHE [J].
HAYNES, SN ;
CUEVAS, J ;
GANNON, LR .
HEADACHE, 1982, 22 (03) :122-132
[7]   Botulinum toxin injection for cervicogenic headache [J].
Hobson, DE ;
Gladish, DF .
HEADACHE, 1997, 37 (04) :253-255
[8]  
Jankovic J, 1988, Adv Neurol, V49, P467
[9]   Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases [J].
Jitpimolmard, S ;
Tiamkao, S ;
Laopaiboon, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (06) :751-757
[10]   THE WEST HAVEN YALE MULTIDIMENSIONAL PAIN INVENTORY (WHYMPI) [J].
KERNS, RD ;
TURK, DC ;
RUDY, TE .
PAIN, 1985, 23 (04) :345-356